808 related articles for article (PubMed ID: 22644022)
41. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
[TBL] [Abstract][Full Text] [Related]
42. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
[TBL] [Abstract][Full Text] [Related]
43. Evidence that methylation of hepatitis B virus covalently closed circular DNA in liver tissues of patients with chronic hepatitis B modulates HBV replication.
Guo Y; Li Y; Mu S; Zhang J; Yan Z
J Med Virol; 2009 Jul; 81(7):1177-83. PubMed ID: 19475606
[TBL] [Abstract][Full Text] [Related]
44. Hepatitis B virus e antigen production is dependent upon covalently closed circular (ccc) DNA in HepAD38 cell cultures and may serve as a cccDNA surrogate in antiviral screening assays.
Zhou T; Guo H; Guo JT; Cuconati A; Mehta A; Block TM
Antiviral Res; 2006 Nov; 72(2):116-24. PubMed ID: 16780964
[TBL] [Abstract][Full Text] [Related]
45. Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA.
Delaney WE; Miller TG; Isom HC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2017-26. PubMed ID: 10428929
[TBL] [Abstract][Full Text] [Related]
46. An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.
Tang L; Remiszewski S; Snedeker A; Chiang LW; Shenk T
Antiviral Res; 2024 Jun; 226():105888. PubMed ID: 38641024
[TBL] [Abstract][Full Text] [Related]
47. Hepatitis B Virus Core Protein Is Not Required for Covalently Closed Circular DNA Transcriptional Regulation.
Zhong Y; Wu C; Xu Z; Teng Y; Zhao L; Zhao K; Wang J; Wang W; Zhan Q; Zhu C; Chen X; Liang K; Cheng X; Xia Y
J Virol; 2022 Nov; 96(21):e0136222. PubMed ID: 36226986
[TBL] [Abstract][Full Text] [Related]
48. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism.
Niu C; Li L; Daffis S; Lucifora J; Bonnin M; Maadadi S; Salas E; Chu R; Ramos H; Livingston CM; Beran RK; Garg AV; Balsitis S; Durantel D; Zoulim F; Delaney WE; Fletcher SP
J Hepatol; 2018 May; 68(5):922-931. PubMed ID: 29247725
[TBL] [Abstract][Full Text] [Related]
49. Virological Basis for the Cure of Chronic Hepatitis B.
Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
[TBL] [Abstract][Full Text] [Related]
50. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
Chen Y; Yao Y; Zhao K; Liu C; Yuan Y; Sun H; Huang D; Zheng Y; Zhou Y; Chen J; Wang Y; Wu C; Zhang B; Guan Y; Li F; Pei R; Chen X
J Virol; 2022 Jul; 96(13):e0058522. PubMed ID: 35862693
[TBL] [Abstract][Full Text] [Related]
51. PCR mediated recombination impacts the analysis of hepatitis B Virus covalently closed circular DNA.
Suspène R; Thiers V; Vartanian JP; Wain-Hobson S
Retrovirology; 2016 Dec; 13(1):84. PubMed ID: 27998270
[TBL] [Abstract][Full Text] [Related]
52. Antiviral strategies to eliminate hepatitis B virus covalently closed circular DNA (cccDNA).
Revill P; Locarnini S
Curr Opin Pharmacol; 2016 Oct; 30():144-150. PubMed ID: 27639371
[TBL] [Abstract][Full Text] [Related]
53. Does Tyrosyl DNA Phosphodiesterase-2 Play a Role in Hepatitis B Virus Genome Repair?
Cui X; McAllister R; Boregowda R; Sohn JA; Cortes Ledesma F; Caldecott KW; Seeger C; Hu J
PLoS One; 2015; 10(6):e0128401. PubMed ID: 26079492
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro.
Delmas J; Schorr O; Jamard C; Gibbs C; Trépo C; Hantz O; Zoulim F
Antimicrob Agents Chemother; 2002 Feb; 46(2):425-33. PubMed ID: 11796353
[TBL] [Abstract][Full Text] [Related]
55. Mapping the Interactions of HBV cccDNA with Host Factors.
Mohd-Ismail NK; Lim Z; Gunaratne J; Tan YJ
Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480501
[TBL] [Abstract][Full Text] [Related]
56. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance.
Tu T; Zehnder B; Qu B; Ni Y; Main N; Allweiss L; Dandri M; Shackel N; George J; Urban S
Antiviral Res; 2020 Sep; 181():104865. PubMed ID: 32726641
[TBL] [Abstract][Full Text] [Related]
57. Rapid Turnover of Hepatitis B Virus Covalently Closed Circular DNA Indicated by Monitoring Emergence and Reversion of Signature-Mutation in Treated Chronic Hepatitis B Patients.
Huang Q; Zhou B; Cai D; Zong Y; Wu Y; Liu S; Mercier A; Guo H; Hou J; Colonno R; Sun J
Hepatology; 2021 Jan; 73(1):41-52. PubMed ID: 32189364
[TBL] [Abstract][Full Text] [Related]
58. A Role for the Host DNA Damage Response in Hepatitis B Virus cccDNA Formation-and Beyond?
Schreiner S; Nassal M
Viruses; 2017 May; 9(5):. PubMed ID: 28531167
[TBL] [Abstract][Full Text] [Related]
59. Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
Allweiss L; Volz T; Giersch K; Kah J; Raffa G; Petersen J; Lohse AW; Beninati C; Pollicino T; Urban S; Lütgehetmann M; Dandri M
Gut; 2018 Mar; 67(3):542-552. PubMed ID: 28428345
[TBL] [Abstract][Full Text] [Related]
60. Recent advances in the study of hepatitis B virus covalently closed circular DNA.
Ji M; Hu K
Virol Sin; 2017 Dec; 32(6):454-464. PubMed ID: 29280054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
